Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Miltefosine to Treat Mucocutaneous Leishmaniasis

This study has been completed.
Information provided by (Responsible Party):
Knight Therapeutics (USA) Inc Identifier:
First received: January 12, 2010
Last updated: March 24, 2015
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)